Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
Crossref DOI link: https://doi.org/10.1038/s41423-022-00882-1
Published Online: 2022-05-30
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ding, Shu
Rao, Yu
Lu, Qianjin
Text and Data Mining valid from 2022-05-30
Version of Record valid from 2022-05-30
Article History
Received: 1 May 2022
Accepted: 5 May 2022
First Online: 30 May 2022
Competing interests
: The authors declare no competing interests.